Autors: Molina Sócola FE. Sanchez Vicente JL. Moruno Rodriguez A.

Slides:

Advertisements

Similar presentations

PET/CT in Oncology George Segall, M.D. Stanford University.

Advertisements

Colon Cancer Are You at Risk? Colorectal Cancer: What Is It?

Update on Screening of Gastrointestinal Diseases Niraj Jani, M.D. Greater Baltimore Medical Center 1/30/15.

Chirurgia Generale II e Centro di Chirurgia Mininvasiva, Università di Torino Prof. Mario MORINO First International Meeting Colorectal Bleeding: a Multidisciplinary.

CT COLONOSCOPY. Turki Alhazmi,MB.CHB, FRCPC, dABR Interventional Radiology-Body MRI Ass. Prof. Faculty of Medicine Umm Al Qura University Makkah-Saudi.

Colon-Rectal Cancer Keith Bradley, MD National Alliance of Research Associates Programs NARAP.

Integrated Cancer Screening Colorectal Cancer Screening.

Cancer 101: A Cancer Education and Training Program for American Indians & Alaska Natives Cancer 101: A Cancer Education and Training Program for American.

A Colonscope is used to remove or biopsy polyps  Night Prep.

TREATMENT OF LARGE AND GIANT COLORECTAL POLYPS IN THE REAL WORLD UEGW, PARIS, 2007 Association pour le Dépistage du Cancer colorectal dans le Haut-Rhin.

CONFIDENTIAL PillCam ™ COLON PillCam™ COLON has received a CE Mark, but is not cleared for marketing or available for commercial distribution in the USA.

Slides last updated: June 2015 CRC: CLINICAL FEATURES.

Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based fecal occult blood testing: a population-based controlled trial.

Change in bowel habits … 60 year old male Complains of progressive constipation for the past 6 months.

Early detection of a colon cancer on health screening by PET/CT Nan-Jing Peng, MD Department Nuclear Medicine.

Imran Ahmad, MD FACP. Consultant Medical Oncologist, KFSH &RC-Jeddah.

Pathology Report Colorectal Cancer Sahar Najibi April 11 th, 2008.

CRC 45: The steps to eliminating Colorectal Cancer Diana Rusz December 12, 2012.

Colorectal Cancer Screening Colorectal Cancer Screening VT SGNA Conference VT SGNA Conference October 24, 2015 October 24, 2015 Lynn Butterly, MD Lynn.

Breast Cancer By: Febby Quintana. Symptoms for Breast Cancer A lump or thickening on or near breast Any change on size or shape of breast Change in color.

High Quality Screening Colonoscopy Colonoscopy is a common endoscopic procedure, with more than 3 million examinations performed in the United States annually.

OSCE KWH AED 5th Nov Question 1 A 40 years old man good past health complained of sudden onset of palpitation, with chest discomfort, no syncope.

Intermediate Uveitis with VMT syndrome Rupesh Agrawal, Carlos Pavesio Moorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom.

Am J Gastroenterol 2012; 107:1213– June 2012 R3. 김동희 /prof. 이창균.

GI Path Exam 2. Most common neoplastic polyp? Most common location and size of colonic hyperplastic polyps?

Case. Kreem is 53 year old man who is quite healthy with no previous illness. He has noticed changes in his bowel habits for the last few months, with.

Previous cancer screening behavior as predictor of colon cancer screening among women aged 50 and over Rafael Guerrero-Preston DrPH, MPH APHA 135th Annual.

Cal-51 Established from the pleural effusion metastasis of a 45-year-old woman with progressive breast adenocarcinoma (after radio-, chemotherapy and surgery)

Pulmonary artery stent infection

What you need to know about the Fecal Occult Blood Test

Copyright © 2010 American Medical Association. All rights reserved.

Different Tests to Detect Colonic Polyps

Fig. 4. A 50-year-old woman with invasive ductal cancer involving left breast underwent breast MRI and PET-CT. (a, b) On axial breast MRI, irregular and.

Tumors of the colon & rectum

First-Degree Relatives of Colorectal Cancer Patients Are Likely to Show Advanced Colorectal Neoplasia despite a Negative Fecal Immunochemical Test Digestion.

Irritable Bowel Syndrome

Colorectal Cancer Screening

Replacing the Guaiac Fecal Occult Blood Test With the Fecal Immunochemical Test Increases Proportion of Individuals Screened in a Large Healthcare Setting

Cancer screening PROF .MAZIN AL-HAWAZ.

Colorectal Cancer.

South London Genomic Medicine Centre Cancer Cases Dr Alison May Berner ST4 Academic Clinical Fellow in Medical Oncology 4th June 2018.

Using PET in Colorectal Cancer

Pediatric posterior scleritis: a Case report.

Volume 118, Issue 6, Pages (June 2000)

سرطان الثدي Breast Cancer

Figure 1 Imaging of a depressed intramucosal carcinoma

COXIELLA BURNETTI INFECTION AS POSSIBLE CAUSE OF PANUVEITIS

TITLE Authors LOGO INTRODUCTION IMAGING/HISTOLOGY PATIENT DESCRIPTION

Colorectal Natural History Model

Replacing the Guaiac Fecal Occult Blood Test With the Fecal Immunochemical Test Increases Proportion of Individuals Screened in a Large Healthcare Setting

Paraneoplastic Opsoclonus-Myoclonus Syndrome as a New and Single Manifestation of Relapsing Disease in a Patient with Small Cell Lung Cancer Ernest Nadal,

Tumors of the colon & rectum

The role of FDG-PET/CT imaging in early detection of extra-cardiac complications of infective endocarditis K. Orvin, E. Goldberg, H. Bernstine, D. Groshar,

RETINITIS WITH MACULAR INVOLVEMENT IN RENAL TRANSPLANT RECIPIENT

Endogenous endophthalmitis associated to St. agalactiae

CANCER Detection and Treatment

Citation: Cancer Care Ontario

Volume 118, Issue 6, Pages (June 2000)

Endoscopic transcecal appendectomy: a novel option for the treatment of appendiceal polyps Bing-Rong Liu, MD, PhD, Saif Ullah, MD, Liping Ye, MD, Dan.

A–f) Increase in cystic airspace size, presumed to occur due to check-valve mechanism. a–f) Increase in cystic airspace size, presumed to occur due to.

By: Nour-Eldin A Nour-Eldin

Supplementary Figure S5

MPGES is expressed in epithelial cells in benign and malignant tumors of the colon. mPGES is expressed in epithelial cells in benign and malignant tumors.

Fig. 5. A 62-year-old woman with mixed invasive ductal and mucinous cancer involving left breast underwent breast MRI and PET-CT. (a) On axial breast MRI,

Principles and Practice of Radiation Therapy

A 63-year-old female with lung adenocarcinoma treated with nivolumab, who experienced pseudoprogression. A 63-year-old female with lung adenocarcinoma.

Change in FES uptake in the tumor during fulvestrant treatment.

Progastrin staining in colon adenomas and adenocarcinomas.

Anemia and Delayed Colon Cancer Diagnosis

Presentation transcript:

OCULAR PARANEOPLASTIC SYNDROME AS INITIAL PRESENTATION OF COLON ADENOCARCINOMA Autors: Molina Sócola FE. Sanchez Vicente JL. Moruno Rodriguez A. Lopez Herrero F.

CASE REPORT Female 66 years old. History of mastectomy by breast cancer 4 years ago. Treatment with anastrozole. Progressive loss of vision in RE. BCVA: light perception / 0,4. Vitritis.

RETINOGRAPHY AND FAG RE LE SYSTEMIC STUDY NEGATIVE IMMUNOCHEMICAL FECAL OCCULT BLOOD TEST + (3) DX. VILLOUS ADENOMA OF COLON BY ENDOSCOPIC STUDY PLANNING: EXCISION BY COLONOSCOPY AND BYOPSIA CANCER EXTENSION STUDY NEGATIVE FDG-PET UPTAKE IN COLONIC VILLOUS ADENOMA